Evidence map›Paper›PMID 42797518›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Juan A Castillo-Garit, Josue Pozo-Martinez, Esteban Rocha-Valderrama, Cristian Rojas-Peña, Karen Acosta-Quiroga, Vicente J Arán, Claudio Olea-Azar, Gerardo M Casañola-Martin, Bakhtiyor Rasulev, Francisco Torrens and 2 more

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Juan A Castillo-GaritInstituto Universitario de Investigación y Desarrollo Tecnológico (IDT), Universidad Tecnológica Metropolitana, Ignacio Valdivieso 2409, San Joaquín, Santiago 8940577, Chile.ORCID 0000-0003-0896-9484
Josue Pozo-MartinezCentro de Investigación, Desarrollo e Innovación de Productos Bioactivos (CinBio), Escuela de Química y Farmacia, Facultad de Farmacia, Universidad de Valparaíso, Av. Gran Bretaña 1093, Valparaiso 2360102, Chile.
Esteban Rocha-ValderramaInstituto Universitario de Investigación y Desarrollo Tecnológico (IDT), Universidad Tecnológica Metropolitana, Ignacio Valdivieso 2409, San Joaquín, Santiago 8940577, Chile.
Cristian Rojas-PeñaInstituto Universitario de Investigación y Desarrollo Tecnológico (IDT), Universidad Tecnológica Metropolitana, Ignacio Valdivieso 2409, San Joaquín, Santiago 8940577, Chile.ORCID 0009-0003-3327-9642
Karen Acosta-QuirogaInstituto Universitario de Investigación y Desarrollo Tecnológico (IDT), Universidad Tecnológica Metropolitana, Ignacio Valdivieso 2409, San Joaquín, Santiago 8940577, Chile.
Vicente J AránInstituto de Química Médica (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain.ORCID 0000-0002-3390-7157
Claudio Olea-AzarLaboratorio de Radicales Libres y Antioxidantes, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago 8330015, Chile.
Gerardo M Casañola-MartinDepartment of Coatings and Polymeric Materials, North Dakota State University, Fargo, ND 58102, USA.ORCID 0000-0003-0383-2032
Bakhtiyor RasulevDepartment of Coatings and Polymeric Materials, North Dakota State University, Fargo, ND 58102, USA.ORCID 0000-0002-7845-4884
Francisco TorrensInstitut Universitari de Ciència Molecular, Universitat de Valencia, 46010 Valencia, Spain.ORCID 0000-0002-8534-208X
Facundo Pérez-GiménezResearch Unit of Radiopharmacy and Stability Drugs, Universidad de Valencia, 46010 Valencia, Spain.ORCID 0000-0002-2212-9812
Mauricio Moncada-BasualtoInstituto Universitario de Investigación y Desarrollo Tecnológico (IDT), Universidad Tecnológica Metropolitana, Ignacio Valdivieso 2409, San Joaquín, Santiago 8940577, Chile.ORCID 0000-0003-1733-9126

Funding

Fondecyt: Fondecyt Inicio 11240973Universidad del Azuay: Proyecto Interno UDA 2024-0111Universidad Tecnológica Metropolitana: Competition for Research Regular Projects, year 2023, code LPR23-11
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

1,2-disubstituted nitroindazolin-3-oneChagas diseaseoxidative stressrandom foresttrypanocidal activity

Identifiers

PMID42797518
PMCPMC13610718

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.